Diamond S G, Markham C H
J Neural Transm. 1976;38(3-4):259-69. doi: 10.1007/BF01249443.
Excess mortality, i.e. more deaths than expected in a similar normal population, has been reduced in Parkinson's disease by levodopa. A California series and a large collaborative study throughout the United States show the ratio of observed to expected deaths to be normal. In contrast, a New York study was similar patients and a Montreal group of much more severely disabled patients showed greater mortality. The reasons for these differences are unclear, but some variations in results may be attributed to different methods of calculating expected deaths to derive the ratio of observed to expected deaths.
帕金森病患者的超额死亡率,即比类似正常人群预期死亡人数更多的情况,已通过左旋多巴得到降低。加利福尼亚的一项研究系列以及美国一项大型合作研究表明,观察到的死亡人数与预期死亡人数之比是正常的。相比之下,一项纽约的研究以及蒙特利尔一组残疾程度更严重得多的患者显示出更高的死亡率。这些差异的原因尚不清楚,但结果的一些差异可能归因于计算预期死亡人数以得出观察到的死亡人数与预期死亡人数之比的不同方法。